HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mixed mesodermal tumors of the uterus. Clinico-pathologic characteristics of 23 patients].

Abstract
The clinical and pathological features, histogenesis and treatment of 23 cases of mixed mesodermal tumours of the uterus (15 benign and 8 malignant) in woman aged from 27 to 78 years (mean 51.25) are reviewed. The tumours manifested by non-specific symptoms, most often uterine bleeding, arising suspicion of malignancy in only two cases. Unlike malignant mixed mesodermal tumours, differentiation of adenofibromas from low-grade adenosarcomas was often very difficult, and needed careful pathohistological analysis of extirpated tissues, including all available histochemical, immunohistochemical and EM procedures. Two cases of adenofibromas recurred as adenosarcomas after four months and five years respectively. Poor prognosis of malignant variants of mixed mesodermal tumours and their difficult differentiation from adenofibromas require close collaboration of pathologists and gynaecologists, implicating hysterectomy as proposed treatment and permanent clinical monitoring.
AuthorsN S Ostojić, G M Vujanić, Z Sretenović, D Dojcinov
JournalSrpski arhiv za celokupno lekarstvo (Srp Arh Celok Lek) 1992 Mar-Apr Vol. 120 Issue 3-4 Pg. 127-31 ISSN: 0370-8179 [Print] Serbia
Vernacular TitleMesoviti mezodermni tumori uterusa klinicko-patoloske osobenosti 23 bolesnika.
PMID1334577 (Publication Type: English Abstract, Journal Article)
Topics
  • Adult
  • Aged
  • Female
  • Humans
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal (pathology)
  • Uterine Neoplasms (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: